HomeASBP • NASDAQ
add
Aspire Biopharma Holdings Inc
Previous close
$1.03
Day range
$0.95 - $1.09
Year range
$0.55 - $35.01
Market cap
5.07M USD
Avg Volume
447.14K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 4.26K | — |
Operating expense | 15.98M | 2,394.83% |
Net income | -4.71M | -537.47% |
Net profit margin | -110.48K | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.00M | 27,532.92% |
Total assets | 1.31M | 786.66% |
Total liabilities | 7.69M | 355.46% |
Total equity | -6.38M | — |
Shares outstanding | 5.02M | — |
Price to book | -0.57 | — |
Return on assets | -2,150.66% | — |
Return on capital | 1,976.04% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -4.71M | -537.47% |
Cash from operations | -927.84K | -293.47% |
Cash from investing | — | — |
Cash from financing | -16.53K | 96.64% |
Net change in cash | -944.37K | -7,216.14% |
Free cash flow | -24.69M | -16,393.01% |
About
Founded
2021
Website
